Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2012
06/21/2012US20120157439 Raf inhibitor compounds and methods of use thereof
06/21/2012US20120157436 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
06/21/2012US20120157432 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
06/21/2012US20120157431 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
06/21/2012US20120156219 Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/21/2012DE102011106849A1 Verfahren zur Synthese NN verknüpfter und um die NN Bindung rotationsgehinderter bis-N-heterocyclische Carbene und deren Einsatz als Liganden für Metallkomplexe Process for the synthesis of linked NN and NN bond to the rotationsgehinderter bis-N-heterocyclic carbenes and their use as ligands for metal complexes
06/21/2012CA2822071A1 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
06/21/2012CA2822003A1 Imidazopyridines as respiratory syncytial virus antiviral agents
06/21/2012CA2821837A1 2-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012CA2821834A1 6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012CA2821829A1 Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012CA2821827A1 6-thio-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012CA2821819A1 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012CA2821817A1 Substituted 6-imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012CA2821777A1 Substituted pyrimido[1,2-b]indazoles and their use as modulators of the pi3k/akt pathway
06/21/2012CA2820078A1 Tricyclic pi3k inhibitor compounds and methods of use
06/21/2012CA2812294A1 Conductive open frameworks
06/21/2012CA2812223A1 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
06/20/2012EP2465860A1 Phthalocyanine compound, preparation method therefor, and coloring composition including said phthalocyanine compound
06/20/2012EP2465505A1 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/20/2012EP2465498A1 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
06/20/2012EP2464650A2 Processes for preparing pemetrexed
06/20/2012EP2464649A1 Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
06/20/2012EP2464648A1 Crystalline compound of 7-[(3r)-3-amino-1-oxo-4-(2, 4, 5-trifluorphenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluormethyl)-1, 2, 4 -triazolo[4,3-a]pyrazine
06/20/2012EP2464641A1 Pyrimidine compounds as tuberculosis inhibitors
06/20/2012EP2464355A1 Substituted triazolophthalazine derivatives
06/20/2012EP2464354A1 Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor
06/20/2012EP2464231A1 Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof
06/20/2012EP2464227A1 Compounds and methods of use thereof
06/20/2012EP2250178B1 Improved process for preparation of triazol-benzodiazepine derivatives
06/20/2012EP2152707B1 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists
06/20/2012EP2144881B1 Isoquinolinone derivatives, processes for their preparation and their use in the treatment of chronic obstructive pulmonary disease ( copd ) and asthma
06/20/2012EP1912996B1 Macrocyclic inhibitors of hepatitis c virus
06/20/2012EP1858895B1 Piperazine-piperidines with cxcr3 antagonist activity
06/20/2012CN1906183B N-acylsulfonamide apoptosis promoters
06/20/2012CN102510862A 5-HT3 receptor modulators, methods of making, and use thereof
06/20/2012CN102504213A Soluble benzenetetracarboxylic diimide group-containing full-conjugated polymer and preparation method thereof
06/20/2012CN102503947A Photosensitizer chlorin e6 titanium compound for treating tumors by photo-oxygen dynamic and preparation method thereof
06/20/2012CN102503946A Gas phase process decolorization method of methenamine mother liquor and decolorization device thereof
06/20/2012CN102503945A Compound capable of inhibiting epidermal growth factor receptor and application thereof
06/20/2012CN102503942A Fluoroquinolone derivative and preparation and medicinal application thereof
06/20/2012CN102503829A Preparation methods for sitagliptin intermediates
06/20/2012CN101312972B Bicyclic cinnamide compound
06/19/2012US8202990 Polo-like kinase inhibitors
06/19/2012US8202878 Type 2 diabetes, obesity, elevated plasma triglycerides, metabolic syndrome, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease;Trans [4-(4-{3-[2-(1-adamantyl)-2-hydroxyethoxy]-1H-pyrazol-5-yl}phenyl)cyclohexyl]acetic acid
06/19/2012US8202858 Vasopressin V1a antagonists
06/19/2012US8202854 Heterocyclic aspartyl protease inhibitors
06/19/2012CA2684169C Smac mimetic dimers and trimers useful as anti-cancer agents
06/19/2012CA2683939C Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
06/19/2012CA2504448C Transcription factor modulating compounds and methods of use thereof
06/14/2012WO2012078915A1 Macrocyclic inhibitors of flaviviridae viruses
06/14/2012WO2012078902A2 Proteostasis regulators
06/14/2012WO2012078859A2 Protein kinase d inhibitors
06/14/2012WO2012078855A1 Substituted pyrazolopyrimidines as glucocerebrosidase activators
06/14/2012WO2012078844A1 Hiv integrase inhibitors
06/14/2012WO2012078834A1 Hiv integrase inhibitors
06/14/2012WO2012078777A1 Bicyclic compounds as pim inhibitors
06/14/2012WO2012078633A2 Methods of inhibiting metastasis from cancer
06/14/2012WO2012077932A2 Novel pyrazole pyridine derivative or pharmaceutically acceptable salts thereof, method for producing same, and pharmaceutical composition including same
06/14/2012WO2012077853A1 Process for preparing caspofungin and novel intermediates thereof
06/14/2012WO2012076973A2 Novel salts of dipeptidyl peptidase iv inhibitor
06/14/2012WO2012076886A2 Novel process and compounds
06/14/2012WO2012076673A1 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
06/14/2012WO2012075744A1 Pharmaceutical composition comprising pyrazolopyrimidinone-like compound
06/14/2012WO2012075683A1 [1,2,4]triazolo[4,3-b][1,2,4]triazine compound, preparation method and use thereof
06/14/2012WO2012050315A3 Azetidinium salt as fp-cit precursor, method for selectively preparing same, and fp-cit synthesis
06/14/2012US20120149902 Pyrrolo[2,3-d]pyrimidine derivative
06/14/2012US20120149898 Dihydrodiazepines useful as inhibitors of protein kinases
06/14/2012US20120149734 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/14/2012US20120149721 Methylpyrrolopyrimidinecarboxamides
06/14/2012US20120149691 Pyrrolo [1,2-b] Pyridazine Derivatives as Janus Kinase Inhibitors
06/14/2012US20120149688 Platelet adp receptor inhibitors
06/14/2012US20120149684 Akt inhibitors
06/14/2012US20120149683 Substituted aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
06/14/2012US20120149682 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
06/14/2012US20120149681 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
06/14/2012US20120149676 Novel compounds
06/14/2012US20120149662 Heterocyclic Compounds as Janus Kinase Inhibitors
06/14/2012US20120149637 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/14/2012US20120148531 Fused heterocyclic derivatives and methods of use
06/14/2012US20120146012 Heterocyclic Radical or Diradical, The Dimers, Oligomers, Polymers, Dispiro Compounds and Polycycles Thereof, the Use Thereof, Organic Semiconductive Material and Electronic or Optoelectronic Component
06/14/2012US20120144903 Method of extracting chlorophyll and measuring consistency of chlorophyll
06/14/2012CA2820838A1 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
06/14/2012CA2820389A1 [1,2,4]triazolo[4,3-b][1,2,4]triazine compound, preparation method and use thereof
06/14/2012CA2820362A1 Substituted pyrazolopyrimidines as glucocerebrosidase activators
06/14/2012CA2820262A1 Bicyclic pyrazole compounds as allosteric modulators of mglur5 receptors
06/14/2012CA2819824A1 Macrocyclic inhibitors of flaviviridae viruses
06/14/2012CA2819810A1 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
06/14/2012CA2819373A1 Bicyclic compounds as pim inhibitors
06/13/2012EP2463289A1 Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
06/13/2012EP2462144A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
06/13/2012EP2462143A1 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives as c-met tyrosine kinase modulators
06/13/2012EP2462142A1 Metabotropic glutamate receptor modulators
06/13/2012EP2462141A1 Novel azaheterocyclic compounds
06/13/2012EP2462127A1 Processes for the preparation of vardenafil
06/13/2012EP2461684A2 Mesoionic pesticides
06/13/2012EP1989205B1 Thiophene-carboxamides useful as inhibitors of protein kinases
06/13/2012EP1798234B1 Pharmaceutical composition comprising temozolomide ester
06/13/2012CN1997642B 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
06/13/2012CN1968955B Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 573